bronchodilator articles & resources on Made-in-China.com

GSK Have Received Marketing Authorization From The European Commission for Relvar Ellipta

Nov 20, 2013

GlaxoSmithKline (GSK) and Theravance have received marketing authorization from the European Commission (EC) for their jointly-developed asthma and chronic obstructive pulmonary disease (COPD) drug 'Relvar Ellipta'. Relvar, which is a ...

Tags: GSK, Relvar Ellipta

Pulmatrix Has Released Positive Results From Initial Stage of Phase IB Clinical Trial

Oct 31, 2013

Pulmatrix has released positive results from initial stage of Phase IB clinical trial of a bronchodilator therapy PUR0200 for patients with chronic obstructive pulmonary disease (COPD). The company said PUR0200 is the first small molecule ...

Tags: Pulmatrix, COPD

Boehringer Ingelheim Has Obtained Marketing Approval for Striverdi Respimat

Oct 23, 2013

Boehringer Ingelheim has obtained marketing approval for Striverdi Respimat (olodaterol), a long-lasting bronchodilator indicated for chronic obstructive pulmonary disease (COPD), in the UK, Denmark and Iceland. This approval is based ...

Tags: Striverdi Respimat, Boehringer Ingelheim

FDA Has Recommended The Approval of Investigational Copd Drug in US

Sep 13, 2013

The Pulmonary-Allergy Drugs Advisory Committee (PADAC) of the US Food and Drug Administration (FDA) has recommended the approval of GlaxoSmithKline (GSK) and Theravance's umeclidinium/vilanterol as a treatment for chronic obstructive ...

Tags: Health, Medicine, Investigational Copd Drug

Grupo Ferrer Internacional Has Begun Sales of Adasuve Inhalation Powder

Aug 2, 2013

Grupo Ferrer Internacional, Alexza Pharmaceuticals' commercial partner, has begun sales of Adasuve inhalation powder, pre-dispensed (Staccato Loxapine) in the European Union (EU). The first sale triggered a $1.25m milestone payment to ...

Tags: Inhalation Powder, Grupo

Ultibro Breezhaler Achieved Positive CHMP Opinion for The Treatment of COPD.

Jul 30, 2013

Swiss drugmaker Novartis has announced that once-daily dual bronchodilator, Ultibro Breezhaler (QVA149), has achieved positive CHMP opinion for the treatment of chronic obstructive pulmonary disease (COPD). Ultibro Breezhaler was ...

Tags: Novartis, once-daily dual bronchodilator

GSK Submitted a New Drug Application to The US FDA for Umeclidinium Bromide Monotherapy

May 3, 2013

GlaxoSmithKline (GSK) has submitted a new drug application (NDA) to the US FDA for umeclidinium bromide (UMEC) monotherapy 62.5mcg to treat chronic obstructive pulmonary disease (COPD). The investigational once-daily UMEC, administered ...

Tags: GlaxoSmithKline, FDA Approval, chronic obstructive pulmonary disease

GSK and Theravance Have Announced The Submission of a Regulatory Application in Japan

Apr 26, 2013

GSK and Theravance have announced the submission of a regulatory application for Anoro Ellipta (UMEC/VI) (62.5/25mcg and 125/25mcg doses) in Japan. UMEC/VI combines a long-acting muscarinic antagonist (LAMA) GSK573719 or umeclidinium ...

Tags: GSK, Medicine

GlaxoSmithKline and Theravance Have Announced The MAA Submission for Anoro

Jan 11, 2013

GlaxoSmithKline and Theravance have announced the MAA submission for Anoro in Europe for patients with chronic obstructive pulmonary disease (COPD). The COPD therapy, administered using the ELLIPTA inhaler, is a combination of GSK573719 ...

Tags: GlaxoSmithKline, COPD therapy, chronic obstructive pulmonary disease

GSK and Theravance Have Submitted a Regulatory Application in The US

Dec 20, 2012

GlaxoSmithKline (GSK) and Theravance have submitted a regulatory application in the US for the investigational once-daily LAMA/LABA combination medicine, umeclidinium bromide (UMEC/VI), to treat chronic obstructive pulmonary disease (COPD) ...

Tags: GlaxoSmithKline, regulatory application, Medicine, FDA

Sosei Group Corporation Received a Positive Opinion for Its Seebri Breezhaler

Dec 5, 2012

Sosei Group Corporation,Japan, has received a positive opinion for its Seebri Breezhaler (glycopyrronium bromide/NVA237),a type of bronchodilator, from European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP). ...

Tags: Seebri Breezhaler, bronchodilator, CHMP, Positive Chmp Opinion

bronchodilator

Related Products